✦ LIBER ✦

URSODEOXYCHOLIC ACID IN PRIMARY BILIARY CIRRHOSIS

✍ Scribed by Bateson, MalcolmC.; Ross, PeterE.; Diffey, BrianL.

Book ID: 123385584
Publisher: The Lancet
Year: 1989
Tongue: English
Weight: 331 KB
Volume: 333
Category: Article
ISSN: 0140-6736
DOI: 10.1016/S0140-6736(89)92888-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ursodeoxycholic acid in primary biliary

Ursodeoxycholic acid in primary biliary cirrhosis: Reply

✍ Ulrich Beuers; Michael Trauner 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Higher doses of ursodeoxycholic acid in

Higher doses of ursodeoxycholic acid in primary biliary cirrhosis?

✍ E. Roda; F. Azzaroli; G. Nigro; F. Piazza; F. Ferrara; S. Liva; S. Giovannelli; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 158 KB

Determining the most efficacious dose of

Determining the most efficacious dose of ursodeoxycholic acid in primary biliary cirrhosis

✍ Verma, A; Jazrawi, RP; Ahmed, HA; Davis, T; Bland, M; Benson, M; Orchard, RT; Th 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 176 KB

Budesonide combined with ursodeoxycholic

Budesonide combined with ursodeoxycholic acid in primary biliary cirrhosis with advanced liver damage

✍ B. Pagán; J.C. Erdozain; C. Comas; S. Martín-Chávarri; M. López; J.F. Gómez-Cere 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 212 KB

Combined analysis of randomized controll

Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis

✍ RE Poupon; KD Lindor; K Cauch-Dudek; ER Dickson; R Poupon; EJ Heathcote 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 354 KB

A randomized trial comparing colchicine

A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis

✍ R E Poupon; P M Huet; R Poupon; A Bonnand; J T Van Nhieu; E S Zafrani 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 214 KB 👁 2 views

The efficacy of colchicine combined with ursodeoxycholic acid (UDCA) and UDCA alone in the treatment of patients with nonadvanced primary biliary cirrhosis (PBC) was evaluated in a 2-year controlled study. Seventy-four patients with PBC who had been treated previously with UDCA (at least 8 months) b